Objective Evaluation of the Effect of Oculoplastic Operations Using the Vectra M 3D Imaging System

NCT ID: NCT06040671

Last Updated: 2023-09-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-05-03

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

An objective assessment of that part of the spectrum of ophthalmic eyelid surgeries that focuses on correcting the position of entropy (e.g. ectropion, ptosis surgery) is very difficult - although it is possible to use different measuring parameters (distance of pupillary reflexes from the edges of the eyelid), comparing different distances on the face, exophthalmometry or the lid laxity test - the so-called snap-back test, but all these methods are based either on the subjective assessment of the examiner or on the correctness of the attached ruler, and their objectivity is therefore very low.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The goal of the project is to develop a methodology for evaluating the results of operations using a stereo photographic system, to objectively evaluate the functionality and results of various eyelid operations, and subsequently to expand the use of the device in other ophthalmological indications.

Different files will be created where the effect of different operations will be monitored in parallel.

Lateral canthal hinge surgery will be evaluated in the pilot group, and ptosis surgery through an anterior approach will be evaluated in the second group.

In all patients, the position of the eyelids, their change before and after surgery, the periorbital volume, and the relation of the eyelids to the periorbital landscape will be assessed metrically.

The Vectra M3 device will be used for the measurement.

The expected cohort size is 40 patients in each group.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Eyelid Ptoses Ectropion Eyelids Entropion;Eye

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

The study subjects will be divided into two groups.
Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

No masking is used in the study.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Lateral canthal hinge surgery patients

Patients undergoing lateral canthal hinge surgery will be enrolled in this group.

Group Type EXPERIMENTAL

Vectra M3 imaging

Intervention Type OTHER

Study subjects from both arms will undergo Vectra M3 imaging to evaluate the result of the surgery.

Ptosis surgery patients

Patients undergoing ptosis surgery will be enrolled in this group.

Group Type EXPERIMENTAL

Vectra M3 imaging

Intervention Type OTHER

Study subjects from both arms will undergo Vectra M3 imaging to evaluate the result of the surgery.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Vectra M3 imaging

Study subjects from both arms will undergo Vectra M3 imaging to evaluate the result of the surgery.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Eyelid ptosis
* Eyelid entropion
* Eyelid ectropion

Exclusion Criteria

* Refusal to participate in the study
* Not signing the Informed Consent Form
* Inability/reluctance to cooperate in the study
Minimum Eligible Age

4 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital Ostrava

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Adam Kopecký, MD,PhD,FEBO

Role: PRINCIPAL_INVESTIGATOR

University Hospital Ostrava

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital Ostrava

Ostrava, Moravian-Silesian Region, Czechia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Czechia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jiří Hynčica

Role: CONTACT

0042059737 ext. 2587

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jiří Hynčica

Role: primary

0042059737 ext. 2587

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

28/RVO-FNOs/2021

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Adaptive Optics Retinal Imaging
NCT02317328 RECRUITING